EyePoint initiated at buy by Citi on wAMD drug potential
[ad_1]
EyePoint initiated at buy by Citi on wAMD drug potential
[ad_2]
Similar Posts
Tencent says its name in the DoD's Chinese military company list is 'a mistake'
Byadmin
[ad_1] Tencent says its name in the DoD's Chinese military company list is 'a mistake' [ad_2]
Phillips 66 CEO sees refining rebound, advantage for U.S. refiners vs. Europe
Byadmin
[ad_1] Phillips 66 CEO sees refining rebound, advantage for U.S. refiners vs. Europe [ad_2]
Goldman Sachs sees almost 30% correction risk in stocks
Byadmin
[ad_1] Goldman Sachs sees almost 30% correction risk in stocks [ad_2]
Tesla falls short of Q4 and full-year deliveries expectations
Byadmin
[ad_1] Tesla falls short of Q4 and full-year deliveries expectations [ad_2]
B2BROKER and Spotware Announce Full Integration of B2COPY with cTrader
Byadmin
[ad_1] PRWire: Aug. 29, 2024 – B2BROKER, a prominent technology provider known for its innovative investment platform B2COPY, has officially announced the complete integration of B2COPY with Spotware’s cTrader, the leading Open Trading Platform™. This partnership allows brokers and traders using cTrader to leverage the combined benefits of both platforms, enhancing their copy trading capabilities…
Trust Stamp announces pricing of $3.5M registered direct offering
Byadmin
[ad_1] Trust Stamp announces pricing of $3.5M registered direct offering [ad_2]